Current Issues & Communications

Companion Diagnostics 

Direct-to-Consumer Marketing of Genetic Tests 

Gene Patents

Genetic Test Registry 

Office of Public Health Genomics 5-year Strategic Plan (Comments, July 2011)

Physician Signature Required (Comments, July 2011)

Oversight of Laboratory-Developed Tests 

Standard Reference Materials 

Whole Genome Analysis 

 

Home / Advocacy

AMP on Capitol Hill and Federal Agencies

AMP is the Voice of Molecular Pathology to Public Policy Leaders

AMP, through its member leaders and its staff, advocates for the profession of molecular pathology and for the ability of its diverse membership to best serve patients. AMP is active in the legislative, regulatory, and reimbursement arenas. 

Recent NEWS

The testimony of AMP President, Dr. Karen Mann, to the U.S. House of Representatives Committee on Science & Technology regarding the need for standard reference materials is featured on their website. Dr. Mann also presented these needs on June 9, by invitation, to the National Institute of Standards & Technology (NIST) Visiting Committee on Advanced Technology. The comments were prepared by AMP’s Clinical Practice Committee.

At their public meeting July 19-20, AMP cautioned FDA regarding unintended consequences, including the potential loss of ability to provide innovative tests, loss of ability to respond rapidly to emerging health threats, and potential discontinuation of needed services to patients.  Comments were prepared by AMP's Professional Relations Committee.